Paper Details

  1. Home
  2. Paper Details

Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.

Author: AltamuraA C, GuercettiG, MauriM C

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Viloxazine was effective in treating depression in both young and elderly patients. Elderly patients showed higher steady-state plasma levels and level/dose ratios compared to younger patients. The drug was well tolerated in elderly patients, making it suitable for use in ambulant geriatric depressed patients.
Paper Details　
Original Abstract of the Article :
Authors studied 42 depressed patients of both sexes suffering from Major Depression and Dysthimic Disorder, treated with viloxazine for 4 weeks. All patients were divided into two groups on the basis of their age (Group 1 mean age 45 +/- 2.2 and Group 2 mean age 68.3 +/- 1.12). Viloxazine was effect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0278-5846(86)90045-x

データ提供：米国国立医学図書館（NLM）

Viloxazine: A Journey Through the Depths of Depression

This study delves into the challenging realm of mental health, exploring the effectiveness of viloxazine, an antidepressant medication, in treating depressive patients of different ages. The researchers analyzed the clinical outcomes of a cohort of patients, comparing the responses of younger and older individuals to viloxazine treatment. Their findings suggest that viloxazine is effective in treating depression regardless of age, highlighting its potential as a valuable therapeutic option across the lifespan.

Viloxazine: A Beacon of Hope for Depressed Individuals

The study's findings demonstrate that viloxazine is effective in alleviating depressive symptoms in both younger and older patients. This suggests that viloxazine can be a valuable therapeutic option for individuals of different ages, offering hope for individuals struggling with depression.

Navigating the Sands of Depression: Tailoring Treatment Strategies

This study highlights the importance of individualizing treatment strategies for depressive patients. The researchers observed that while viloxazine was effective across age groups, there were differences in plasma levels and response patterns. This underscores the need for clinicians to consider individual patient factors, such as age, clinical presentation, and potential drug interactions, when developing treatment plans.

Dr. Camel's Conclusion

This study, like a cool spring in the scorching desert of depression, offers hope for individuals struggling with this debilitating condition. Viloxazine demonstrates promise as a valuable therapeutic option for patients of different ages, highlighting its potential to ease suffering and improve quality of life.

Date :
  1. Date Completed 1986-06-10
  2. Date Revised 2019-09-08
Further Info :

Pubmed ID

3704174

DOI: Digital Object Identifier

10.1016/0278-5846(86)90045-x

Related Literature

Article Analysis
・Side Effects of viloxazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.